
Health In Tech fell 69.4% from $1.83 to $0.56, behind the S&P 500's +10.8%. Its worst day was May 14 (−20.1%), and its low came Oct 26 at $0.54.
Nov 12, 2025 – Nov 11, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Health In Tech shares fell 14.2%, while the S&P 500 fell 1.7%.
−14.2% · S&P 500 −1.7%
Health In Tech (Nasdaq: HIT), an Insurtech platform company backed by third-party AI technology, today announced that its executive management team, vice presidents across functions, and Board of Directors have
Story events cover the past 12 months · Times ET
−15.1% · S&P 500 +0.1%
Health In Tech shares rose 15.1%, while the S&P 500 fell 0.2%.
+15.1% · S&P 500 −0.2%
Health In Tech shares rose 20.9%, while the S&P 500 fell 0.4%.
+20.9%, the year's best day · S&P 500 −0.4%
Health In Tech closed at its highest level of the year, 10.9% above where the year started.
+9.1% · S&P 500 +0.9%
EPS of $-0.01 beat the $-0.01 estimate on $7.5M revenue (est. $7.3M); FY revenue guidance of $45.0M–$50.0M against the $41.6M consensus.
−11.0% · S&P 500 −1.8%
Health In Tech shares rose 14.7%, while the S&P 500 fell 0.7%.
+14.7% · S&P 500 −0.7%
EPS of $-0.03 missed the $-0.02 estimate on $4.5M revenue (est. $7.4M); FY revenue guidance of $45.0M–$50.0M against the $46.4M consensus.
−20.1%, the year's worst day · S&P 500 +0.8%
EPS of $-0.04 missed the $-0.03 estimate on $8.1M revenue (est. $7.7M); FY revenue guidance of $45.0M–$50.0M against the $47.0M consensus.
−5.2% · S&P 500 −0.2%
Health In Tech closed at its lowest level of the year, 70.7% below where the year started.
−4.7% · S&P 500 +0.7%
Where it ended: a close of $0.56 on Nov 11, 2026. Up next: Q3 2026 earnings on Nov 12, 2026 (EPS est. $-0.05, revenue est. $6.9M).
Nothing in the past 12 months.
All HIT dividend historyReplay the year: the line draws itself and stops at each of the 10 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for HIT and SPY from Benzinga historical bars. Not investment advice.